← Evidence map

ArticleFrontiers in immunology2025

Loss of ATG5 impairs CD4+ T cell activation and promotes anti-tumor responses.

Carlos Plaza-Sirvent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40977681